Logo image of BIM.PA

BIOMERIEUX (BIM.PA) Stock Fundamental Analysis

EPA:BIM - Euronext Paris - Matif - FR0013280286 - Common Stock - Currency: EUR

119  0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to BIM. BIM was compared to 58 industry peers in the Health Care Equipment & Supplies industry. BIM scores excellent points on both the profitability and health parts. This is a solid base for a good stock. BIM has a decent growth rate and is not valued too expensively. This makes BIM very considerable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

BIM had positive earnings in the past year.
In the past year BIM had a positive cash flow from operations.
BIM had positive earnings in each of the past 5 years.
BIM had a positive operating cash flow in each of the past 5 years.
BIM.PA Yearly Net Income VS EBIT VS OCF VS FCFBIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

With a decent Return On Assets value of 7.49%, BIM is doing good in the industry, outperforming 79.31% of the companies in the same industry.
BIM's Return On Equity of 10.28% is fine compared to the rest of the industry. BIM outperforms 74.14% of its industry peers.
BIM has a Return On Invested Capital of 9.33%. This is amongst the best in the industry. BIM outperforms 81.03% of its industry peers.
BIM had an Average Return On Invested Capital over the past 3 years of 10.05%. This is above the industry average of 8.02%.
Industry RankSector Rank
ROA 7.49%
ROE 10.28%
ROIC 9.33%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
BIM.PA Yearly ROA, ROE, ROICBIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a decent Profit Margin value of 10.86%, BIM is doing good in the industry, outperforming 72.41% of the companies in the same industry.
In the last couple of years the Profit Margin of BIM has remained more or less at the same level.
BIM has a better Operating Margin (14.79%) than 74.14% of its industry peers.
In the last couple of years the Operating Margin of BIM has grown nicely.
Looking at the Gross Margin, with a value of 55.66%, BIM is in line with its industry, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Gross Margin of BIM has remained more or less at the same level.
Industry RankSector Rank
OM 14.79%
PM (TTM) 10.86%
GM 55.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
BIM.PA Yearly Profit, Operating, Gross MarginsBIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BIM is still creating some value.
The number of shares outstanding for BIM remains at a similar level compared to 1 year ago.
BIM has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BIM has an improved debt to assets ratio.
BIM.PA Yearly Shares OutstandingBIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BIM.PA Yearly Total Debt VS Total AssetsBIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

BIM has an Altman-Z score of 6.80. This indicates that BIM is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.80, BIM belongs to the top of the industry, outperforming 91.38% of the companies in the same industry.
BIM has a debt to FCF ratio of 1.53. This is a very positive value and a sign of high solvency as it would only need 1.53 years to pay back of all of its debts.
BIM has a better Debt to FCF ratio (1.53) than 86.21% of its industry peers.
BIM has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
BIM's Debt to Equity ratio of 0.08 is amongst the best of the industry. BIM outperforms 84.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.53
Altman-Z 6.8
ROIC/WACC1.2
WACC7.75%
BIM.PA Yearly LT Debt VS Equity VS FCFBIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 2.20 indicates that BIM has no problem at all paying its short term obligations.
BIM has a Current ratio of 2.20. This is in the better half of the industry: BIM outperforms 65.52% of its industry peers.
A Quick Ratio of 1.29 indicates that BIM should not have too much problems paying its short term obligations.
BIM has a Quick ratio of 1.29. This is in the better half of the industry: BIM outperforms 62.07% of its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.29
BIM.PA Yearly Current Assets VS Current LiabilitesBIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.01% over the past year.
BIM shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.91% yearly.
Looking at the last year, BIM shows a quite strong growth in Revenue. The Revenue has grown by 8.31% in the last year.
Measured over the past years, BIM shows a quite strong growth in Revenue. The Revenue has been growing by 8.27% on average per year.
EPS 1Y (TTM)21.01%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%10.71%
Revenue 1Y (TTM)8.31%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%9.1%

3.2 Future

The Earnings Per Share is expected to grow by 13.37% on average over the next years. This is quite good.
Based on estimates for the next years, BIM will show a small growth in Revenue. The Revenue will grow by 6.35% on average per year.
EPS Next Y20.14%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
EPS Next 5Y13.37%
Revenue Next Year7.29%
Revenue Next 2Y7.04%
Revenue Next 3Y7.59%
Revenue Next 5Y6.35%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BIM.PA Yearly Revenue VS EstimatesBIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
BIM.PA Yearly EPS VS EstimatesBIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 30.83, the valuation of BIM can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of BIM indicates a somewhat cheap valuation: BIM is cheaper than 65.52% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.45. BIM is around the same levels.
BIM is valuated quite expensively with a Price/Forward Earnings ratio of 25.66.
BIM's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.90. BIM is around the same levels.
Industry RankSector Rank
PE 30.83
Fwd PE 25.66
BIM.PA Price Earnings VS Forward Price EarningsBIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BIM indicates a somewhat cheap valuation: BIM is cheaper than 67.24% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BIM is valued a bit cheaper than 63.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF 43.81
EV/EBITDA 15.68
BIM.PA Per share dataBIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

BIM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of BIM may justify a higher PE ratio.
A more expensive valuation may be justified as BIM's earnings are expected to grow with 15.21% in the coming years.
PEG (NY)1.53
PEG (5Y)2.83
EPS Next 2Y16.12%
EPS Next 3Y15.21%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.76%, BIM is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.07, BIM pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.76, BIM pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 0.76%

5.2 History

The dividend of BIM is nicely growing with an annual growth rate of 19.40%!
Dividend Growth(5Y)19.4%
Div Incr Years1
Div Non Decr Years7
BIM.PA Yearly Dividends per shareBIM.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BIM pays out 23.18% of its income as dividend. This is a sustainable payout ratio.
The dividend of BIM is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP23.18%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
BIM.PA Yearly Income VS Free CF VS DividendBIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BIM.PA Dividend Payout.BIM.PA Dividend Payout, showing the Payout Ratio.BIM.PA Dividend Payout.PayoutRetained Earnings

BIOMERIEUX

EPA:BIM (7/4/2025, 7:00:00 PM)

119

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-15 2025-05-15
Earnings (Next)11-03 2025-11-03
Inst Owners20.89%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap14.08B
Analysts75.29
Price Target127.5 (7.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.76%
Yearly Dividend0.85
Dividend Growth(5Y)19.4%
DP23.18%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.57%
PT rev (3m)-1.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.46%
Valuation
Industry RankSector Rank
PE 30.83
Fwd PE 25.66
P/S 3.54
P/FCF 43.81
P/OCF 21.11
P/B 3.35
P/tB 4.72
EV/EBITDA 15.68
EPS(TTM)3.86
EY3.24%
EPS(NY)4.64
Fwd EY3.9%
FCF(TTM)2.72
FCFY2.28%
OCF(TTM)5.64
OCFY4.74%
SpS33.63
BVpS35.53
TBVpS25.2
PEG (NY)1.53
PEG (5Y)2.83
Profitability
Industry RankSector Rank
ROA 7.49%
ROE 10.28%
ROCE 12.7%
ROIC 9.33%
ROICexc 9.83%
ROICexgc 13.6%
OM 14.79%
PM (TTM) 10.86%
GM 55.66%
FCFM 8.08%
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
ROICexc(3y)11.26%
ROICexc(5y)13.92%
ROICexgc(3y)17.24%
ROICexgc(5y)22.12%
ROCE(3y)13.71%
ROCE(5y)16.2%
ROICexcg growth 3Y-22.62%
ROICexcg growth 5Y-8.16%
ROICexc growth 3Y-19.11%
ROICexc growth 5Y-1.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score7
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.53
Debt/EBITDA 0.39
Cap/Depr 106.34%
Cap/Sales 8.69%
Interest Coverage 250
Cash Conversion 73.01%
Profit Quality 74.39%
Current Ratio 2.2
Quick Ratio 1.29
Altman-Z 6.8
F-Score7
WACC7.75%
ROIC/WACC1.2
Cap/Depr(3y)244.38%
Cap/Depr(5y)271.63%
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.66%
Profit Quality(5y)62.08%
High Growth Momentum
Growth
EPS 1Y (TTM)21.01%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%10.71%
EPS Next Y20.14%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
EPS Next 5Y13.37%
Revenue 1Y (TTM)8.31%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%9.1%
Revenue Next Year7.29%
Revenue Next 2Y7.04%
Revenue Next 3Y7.59%
Revenue Next 5Y6.35%
EBIT growth 1Y34.12%
EBIT growth 3Y-7.95%
EBIT growth 5Y10.54%
EBIT Next Year61.98%
EBIT Next 3Y26.54%
EBIT Next 5Y19.07%
FCF growth 1Y200.19%
FCF growth 3Y-15.59%
FCF growth 5Y18.88%
OCF growth 1Y49.82%
OCF growth 3Y-6.82%
OCF growth 5Y10.35%